» Articles » PMID: 32330632

Risk of Hospitalization and Death from COVID-19 Infection in Patients with Chronic Plaque Psoriasis Receiving a Biologic Treatment and Renal Transplant Recipients in Maintenance Immunosuppressive Treatment

Overview
Specialty Dermatology
Date 2020 Apr 25
PMID 32330632
Citations 37
Authors
Affiliations
Soon will be listed here.
Citing Articles

COVID-19 Among Patients with Psoriasis: A Single-Center Retrospective Cross-Sectional Study.

Kaya O, Keskinkaya Z, Isik Mermutlu S, Oguz Kilic S, Cakir H Infect Dis Clin Microbiol. 2024; 5(2):127-135.

PMID: 38633013 PMC: 10986702. DOI: 10.36519/idcm.2023.192.


Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccine.

Railton J, Volonte M, Isoletta E, Bonelli A, Barruscotti S, Brazzelli V Front Immunol. 2024; 15:1354729.

PMID: 38352875 PMC: 10861681. DOI: 10.3389/fimmu.2024.1354729.


The Impact of Immune-Modulating Treatments for Dermatological Diseases on the Risk of Infection with SARS-CoV-2 and Outcomes Associated with COVID-19 Illness.

Maynard N, Armstrong A Curr Dermatol Rep. 2023; 12(2):45-55.

PMID: 37304177 PMC: 10068706. DOI: 10.1007/s13671-023-00385-w.


Inflammation Causes Exacerbation of COVID-19: How about Skin Inflammation?.

Komine M, Ansary T, Hossain M, Kamiya K, Ohtsuki M Int J Mol Sci. 2022; 23(20).

PMID: 36293117 PMC: 9603600. DOI: 10.3390/ijms232012260.


COVID-19 Pandemic Impact on Severe Alopecia Areata Patients.

Gheisari M, Zahedi K, Tehranchinia Z, Moravvej H, Abdollahimajd F, Dadkhahfar S Skin Appendage Disord. 2022; 8(3):195-199.

PMID: 35698587 PMC: 8805067. DOI: 10.1159/000520422.


References
1.
Bashyam A, Feldman S . Should patients stop their biologic treatment during the COVID-19 pandemic. J Dermatolog Treat. 2020; 31(4):317-318. DOI: 10.1080/09546634.2020.1742438. View

2.
Lebwohl M, Rivera-Oyola R, Murrell D . Should biologics for psoriasis be interrupted in the era of COVID-19?. J Am Acad Dermatol. 2020; 82(5):1217-1218. PMC: 7156810. DOI: 10.1016/j.jaad.2020.03.031. View